B1 - Liquid Biopsy Metabolomic Profiling of Neuroendocrine Cancer Patients

Published in 2019 Listed under Basic Science

Nicholas Skill; Elliott Campbell; Tanja Milosavljevic; Elise Chouest; Brianne Voros; Eugene Woltering; Mary Maluccio

Abstract ID: 20

B10 - Development of Anti-SSTR CAR-T Cells for Future Treatment of NETs

Published in 2019 Listed under Applied Basic Science

Barbara Mandriani; Mauro Cives; Eleonora Pellé; Davide Quaresmini; Maria Ramello; Jonathan Strosberg; Daniel Abate-Daga; Franco Silvestris

Abstract ID: 57

B11 - MicroRNA-Based Classification of Neuroendocrine Neoplasms

Published in 2019 Listed under Applied Basic Science

Jina Nanayakkara; Kathrin Tyryshkin; Xiaojing Yang; Justin Wong; Thomas Tuschl; Neil Renwick

Abstract ID: 60

B12 - Duodenal Neuroendocrine Tumors Exhibit Distinct Transcriptome and Mutations Compared to Pancreatic Neuroendocrine Tumors and Ileal Carcinoids

Published in 2019 Listed under Applied Basic Science

Karen Rico; Sulaiman Sheriff; Suzann Duan; Sammed Mandape; Ritu Pandey; Bryson Katona; David Metz; Juanita Merchant

Abstract ID: 65

B13 - Identification of Subtype-Specific Therapeutic Targets for Precision Medicine Applications in Small Cell Lung Cancer

Published in 2019 Listed under Applied Basic Science

Karine Pozo; Rahul Kollipara; Kathia Rodarte; Adi Gazda; John Minna; Jane Johnson

Abstract ID: 69

 

B14 - Dosimetry and Potential Toxicities of 212PB-DOTATOC in a Preclinical Model: Towards Personalized Dosimetry Based Alpha-Particle Therapy for Neuroendocrine Tumors

Published in 2019 Listed under Applied Basic Science

Dongyoul Lee; Stephen Graves; DijieLiu; Hsiang Wen; Diana ZepedaOrozco; Mark Madsen; Susan Walsh; G. Watkins; Yusuf Menda; Michael Schultz; David Bushnell

Abstract ID: 79

B15 - Method for Establishing and Characterizing Small Bowel Neuroendocrine Tumor Organoids

Published in 2019 Listed under Applied Basic Science

Po Hien Ear; Guiying Li; Aaron Scott; Meng Wu; Ellen Abusada; Courtney Kaemmer; Dawn Quelle; Andrew Bellizzi; James Howe

Abstract ID: 84

B16 - Imipridone Onc201 Blocks Tumor Growth by Inhibiting RET/IGFBP2 Pathway in Medullary Thyroid Cancer

Published in 2019 Listed under Applied Basic Science

Rozita Bagheri-Yarmand; Rohinton Tarapore; Joshua Allen; Steven Sherman; Robert Gagel

Abstract ID: 104

B17 - Ocular Metastases of Neuroendocrine Tumors

Published in 2019 Listed under Applied Basic Science

Shria Kumar; Jason Heckert; Bonita Bennett; Bryson Katona; David Metz

Abstract ID: 38

B2 - Upregulation of Immune Signaling Pathways Differentiates Metastaticfrom Localized Pancreatic Neuroendocrine Tumors

Published in 2019 Listed under Basic Science

Jessica Limberg; Akanksha Verma; Timothy Ullmann; Maureen Moore; Dessislava Stefanova; Brendan Finnerty; Toni Beninato; Rasa Zarnegar; Olivier Elemento; Thomas Fahey, III; Irene Min

Abstract ID: 37

B3 - Differential Gene Expression in Metastatic Pancreatic Neuroendocrine Tumors Predicts Novel Therapeutic Agents

Published in 2019 Listed under Basic Science

Aaron Scott; Michelle Weitz; Patrick Breheny; Po Hien Ear; Benjamin Darbro; Bart Brown; Terry Braun; Guiying Li; Ume Salma Shaik Amjad; Courtney Kaemmer; Chandra Kumar Maharjan; Dawn Quelle; Andrew Bellizzi; Joseph Dillon; Thomas O’Dorisio; James Howe

Abstract ID: 106

B4 - RABL6A Promotes PNET Angiogenesis and Development in Vivo

Published in 2019 Listed under Basic Science

Chandra Kumar Maharjan; Courtney Kaemmer; Casey Bauchle; Samuel Stephens; David Meyerholz; Dawn Quelle

Abstract ID: 135

B5 - Autophagy Inhibition Induces Apoptosis on Low-Grade Pancreatic Neuroendocrine Tumor Mouse Model

Published in 2019 Listed under Basic Science

Kenzo Nakano; Toshihiko Masui; Norio Emoto; Akitada Yogo; Yuichiro Uchida; Kazuyuki Nagai; Takayuki Anazawa; Kyoichi Takaori; Yoshiya Kawaguchi; Shinji Uemoto

Abstract ID: 139

B6 - CDK-Targeted Combination Therapies of Pancreatic Neuroendocrine Tumors (PNETs) Guided by Rabl6a-Dependent Regulation of the PNET Kinome and Phosphoproteome

Published in 2019 Listed under Basic Science

Ume Salma Shaik Amjad; Courtney Kaemmer; Chandra Kumar Maharjan; Jordan Kohlmeyer; Laura Herring; Dennis Goldfarb; E. Wilkerson; Ryan Sheehy; Mariah Leidinger; David Meyerholz; Tim Ginader; Gideon Zamba; Andrew Bellizzi; Lee Graves; Benjamin Darbro; Dawn Quelle

Abstract ID: 143

 

 

B7 - Antitumor Efficacy of M3814 as a Radiation Sensitizer in Neuroendocrine Tumor (NET) Preclinical Models

Published in 2019 Listed under Basic Science

Aman Chauhan; Piotr Rychahou; Tadahide Izumi; John Wu; Lowell Anthony; Mark Evers; Charles Kunos

Abstract ID: 150

B8 - Novel Mouse Models of Pancreatic Neuroendocrine Tumor Metastasis

Published in 2019 Listed under Basic Science

Courtney Kaemmer; Umesalma Shaik; Chandra Kumar Maharjan; Devon Moose; Goutham Narla; Benjamin Darbro; Andrew Bellizzi; Micheal Henry; Dawn Quelle

Abstract ID: 158

B9 - CXCR4 as Radio-Theranostic Target for High Grade Lung NETs and NECS

Published in 2019 Listed under Applied Basic Science

Dijie Liu; Mengshi Li; Ying Hong; Claudia Robles-Planells; Edwin Sagastume; Evan Balk; Andrew Bellizzi; Sue O’Dorisio

Abstract ID: 39

C1 - The TELEPATH Phase 3 Study: An Analysis of Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms

Published in 2019 Listed under Clinical

Dieter Horsch; Lowell Anthony; David Gross; Juan Valle; Staffan Welin; Marta Benavent; Kenneth Kassler-Taub; Polina Binder; Phillip Banks; Pablo Lapuerta; Matthew Kulke

Abstract ID: 33

C10 - CLARINET FORTE Baseline Characteristics: Lanreotide Autogel 120 Mg (LAN) Every 14 Days in Patients with Progressive Pancreatic or Midgut Neuroendocrine Tumors During a Standard First-Line LAN Regimen

Published in 2019 Listed under Clinical

Philippe Ruszniewski; Jarosław Ćwikła; Catherine Lombard-Bohas; Ivan Borbath; Tahir Shah; Ulrich-Frank Pape; Xuan-Mai Truong Thanh; Aude Houchard; Marianne Pavel

Abstract ID: 121

C11 - Somatostatin Analog Use in Patients with Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH)

Published in 2019 Listed under Clinical

Taymeyah Al-Toubah; Mintallah Haider; Jonathan Strosberg

Abstract ID: 126

C12 - Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms

Published in 2019 Listed under Clinical

Taymeyah Al-Toubah; Brian Morse; Jonathan Strosberg

Abstract ID: 127

C13 - Tumor Growth Rate (TGR) to Monitor Growth/Predict Response to Lanreotide Autogel Use Before, During and After PRRT in Advanced GEP-NETS: Data from the PRELUDE Study

Published in 2019 Listed under Clinical

Lisa Bodei; Raj Srirajaskanthan; Chiara Maria Grana; Sergio Baldari; Tahir Shah; Angela Lamarca; Frédéric Courbon; Klemens Scheidhauer; Eric Baudin; Gustave Roussy Xuan-Mai; Truong Thanh; Aude Houchard; Vikas Prasad

Abstract ID: 144

 

C14 - Improvement in Carcinoid Syndrome- Related Symptoms with Telotristat Ethyl in Patients with 2 or Less Bowel Movements Per Day

Published in 2019 Listed under Clinical

Valentina Di Gialleonardo; Eshetu Tesfaye; Ashwin Kittur; Susan Giacalone; Pablo Lapuerta

Abstract ID: 145

C16 - Clinical Efficacy and Toxicity Data on Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Aman Chauhan; Susanne Arnold; John Wu; Rashmi Nair; Stacey Slone; Emily Dressler; Heather Flynn; Val Adams; Heidi Weiss; Mark Evers; Lowell Anthony

Abstract ID: 153

C19 - TACE or TARE? Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor

Published in 2019 Listed under Clinical

Brian Currie; Gregory Nadolski; Jeffrey Mondschein; Mandeep Dagli; Deepak Sudheendra; S. William Stavropoulos; Michael Soulen

Abstract ID: 16

C2 - Real-World Comparison of Lanreotide and Octreotide LAR Use for Neuroendocrine Tumours (NETs) in British Columbia, Canada

Published in 2019 Listed under Clinical

Shehara Mendis; Justin Jao; M.K.C. Lee; Sharlene Gill; David Schaeffer; Daniel Renouf; Jonathan Loree

Abstract ID: 50

C20 - 64Cu-DOTATATE Somatostatin Receptor Imaging in Neuroendocrine Tumor Patients: Experience from More Than 600 Patients

Published in 2019 Listed under Clinical

Andreas Kjaer; Tina Binderup; Camilla Johnbeck; Esben Carlsen; Mathias Loft; Seppo Langer; Birgitte Federspiel; Ulrich Knigge

Abstract ID: 25

C21 - Lymphovascular Invasion, Tumor Growth Pattern and Fibrosis in Pancreatic Neuroendocrine Tumors: Qualitative Imaging Correlates on Preoperative CT/MRI in a Series of 136 Cases

Published in 2019 Listed under Clinical

Motoyo Yano; Nikolaos Trikalinos;Greg Williams; Amber Salter; Samantha Lancia; Chet Hammill; William Hawkins; Deyali Chatterjee

Abstract ID: 29

C22 - Evaluation of Small Bowel Neuroendocrine Tumor Metastases by 68Ga-DOTATATE PET/CT: A Single Institution Review

Published in 2019 Listed under Clinical

Hannah Monahan; Ajit Goenka; Michael Wells; Stephen Broski; Annie Packard; Thorvardur Halfdanarson

Abstract ID: 30

C23 - Initial Experience with Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors (NETs) at a Tertiary Care United States Center

Published in 2019 Listed under Clinical

Jason Heckert; Samuel Botterbusch; Sarit Kipnis; Bonita Bennet; Caroline Creamer; Alice Alderson; Jennifer Eads; Michael Soulen; Daniel Pryma; David Mankoff; David Metz; Bryson Katona

Abstract ID: 40

C24 - Granulomatous Fungal Infection Coexistence with NET: Not All That Lights Up on PET Scan is a NET

Published in 2019 Listed under Clinical

Ayca Dundar; Thorvardur Halfdanarson; Ayse Tuba Kendi; Saul Friedman; Michael Bold; Rachel Eiring; Geoffrey Johnson

Abstract ID: 48

C25 - A Personalized Remote Radiation-Tracking Vest for At-Home Monitoring of Lu-177 DOTATATE Therapy

Published in 2019 Listed under Clinical

Larry Pierce; Robert Harrison; Hubert Vesselle; Robert Miyaoka

Abstract ID: 56

C26 - Intra-Arterial Peptide Receptor Radionuclide Therapy Using Y-90 DOTATOC for Hepatic Metastases of Gastroenteropancreatic Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Courtney Lawhn Heath; Nicholas Fidelman; Emily Bergsland; Thomas Hope

Abstract ID: 59

C27 - First U.S. Prospective Evaluation of Performance of Cu-64 DOTATATE PET/CT in Somatostatin Expressing Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Ebrahim Delpassand; Rodolfo Nuñez; David Ranganathan; Nilesh Wagh; Afshin Shafie; Ayman Gaber; Ali Abbasi

Abstract ID: 63

C28 - Efficacy Update on the First Real-World Experience of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET) Since US FDA Approval

Published in 2019 Listed under Clinical

Bhavana Konda; Sherry Mori Vogt; Sherise Rogers; Cassandra Grenade; Claire Verschraegen; Ye Zhou; Ashima Goyal; Mona Natwa; Chadwick Wright; Akram Hussein; Hallie Barr; Dramane Konate; Andrew Brown; Rochelle Batdorf; Bonnie Williams; Lai Wei; Manisha Shah

Abstract ID: 76

C29 - Safety and Response of an Evans Blue-Modified Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE with Increased Effective Dose in the Treatment Of Metastatic Neuroendocrine Tumors: A Pilot Prospective Study

Published in 2019 Listed under Clinical

Qingxing Liu; Yuejuan Cheng; Jie Zang Chinese; Hao Wang; Huimin Sui; Jingjing Zhang; Orit Jacobson; Zhaohui Zhu; Xiaoyuan Chen

Abstract ID: 88

C3 - Xermelo Patient Registry: Improvements in Clinical Outcomes, Patient Satisfaction, and Weight with Telotristat Ethyl in The Real-World

Published in 2019 Listed under Clinical

Mark Price; Vijay Joish; Steven Schwartz; Ann Fish-Steagall; Lee Bennett; Christina Darden; Eshetu Tesfaye; Karie Arnold; Sumon Wason; Pablo Lapuerta

Abstract ID: 77

C30 - Role of Functional Imaging for Response Assessment of Lu177-DOTATATE Therapy

Published in 2019 Listed under Clinical

Erik Mittra; Nadine Mallak; Adam Brown; Bree Murphy; Rodney Pommier

Abstract ID: 102

C31 - Tumor Detection Rates Using Standard Screening Protocols in Patients with SDHX Pathogenic Variants

Published in 2019 Listed under Clinical

Samantha Greenberg; Michelle Jacobs; Heather Wachtel; Amanda Anson; Bonita Bennett; Maria Bonanni; Luke Buchmann; Debbie Cohen; Wendy Kohlmann; Katherine Nathanson; Anne Naumer; Amanda Schaefer; Tobias Else; Lauren Fishbein

Abstract ID: 117

C32 - CT and MRI of Pancreatic Neuroendocrine Tumors Reveal More Than Just a Round, Enhancing Mass: Associations Between “Atypical” Imaging Features

Published in 2019 Listed under Clinical

Motoyo Yano; Deyali Chatterjee; Greg Williams; Amber Salter; Samantha Lancia; Chet Hammill; William Hawkins; Nikolaos Trikalinos

Abstract ID: 119

C33 - Ga-DOTATATE Cardiac Uptake in Carcinoid Heart Disease Patients

Published in 2019 Listed under Clinical

Malak Itani; Manik Amin; Joyce Mhlanga; Nikolaos Trikalinos

Abstract ID: 125

C34 - Toxicity Update on the First Real World Experience of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET) Since US FDA Approval

Published in 2019 Listed under Clinical

Bhavana Konda; Sherry Mori Vogt; Sherise Rogers; Cassandra Grenade; Claire Verschraegen; Ye Zhou; Ashima Goyal; Mona Natwa; Chadwick Wright; Akram Hussein; Hallie Barr; Dramane Konate; Andrew Brown; Rochelle Batdorf; Bonnie Williams; Lai Wei; Manisha Shah

Abstract ID: 133

C36 - Single-Institution Clinical Experience of Toxicity with Lu177-DOTATATE Therapy

Published in 2019 Listed under Clinical

Erik Mittra; Bree Murphy; Adam Brown; Nadine Mallak; Rodney Pommier

Abstract ID: 147

C37 - Comparison of GI Toxicity Associated with AA Formulations Co-Infused With PRRT: Commercial Parenteral Nutrition Formula versus Compounded L-Lysine/L-Arginine

Published in 2019 Listed under Clinical

Dhiraj Sikaria; Jose Jesurajan; Johnna Smith; Jonathan Strosberg; Ghassan El-Haddad

Abstract ID: 160

C38 - SKIE: An Automated Approach to Quantitation of Ki-67 Index from Human Gastrointestinal Neuroendocrine Tumor

Published in 2019 Listed under Clinical

Darshana Govind; Kuang-Yu Jen; Karen Matsukuma; Guofeng Gao; Kristin Olson; Dorina Gui; Pinaki Sarder

Abstract ID: 14

C39 - Operative Resection of Duodenal Carcinoid Tumors: A Single Center Experience

Published in 2019 Listed under Clinical

Shria Kumar; Nadim Mahmud; Bryson Katona; Robert Roses; Gregory Ginsberg; David Metz

Abstract ID: 17

C4 - Real-World Effectiveness of Telotristat Ethyl among Patients with Mild Baseline Diarrhea

Published in 2019 Listed under Clinical

Al Benson; Vijay Joish; Sam Dharba; Pablo Lapuerta; Dipa Sapre; Jonathan Strosberg

Abstract ID: 78

 

 

C40 - Meta-Analysis of Prognostic Biomarkers for Pancreatic Neuroendocrine Tumors (PNETs)

Published in 2019 Listed under Clinical

Mojun Zhu; Thorvardur Halfdanarson; Bonnie Rothberg

Abstract ID: 21

C41 - Novel Use of a CLIA-Certified CDKN2C Loss Assay in Sporadic Medullary Thyroid Carcinoma

Published in 2019 Listed under Clinical

Jessica Maxwell; Maria Gule-Monroe; Vivek Subbiah; Mimi Hu; Nancy Perrier; Maria Cabanillas; Jeffrey Lee; Paul Graham; Gilbert Cote; Naifa Busaidy; Elizabeth Grubbs

Abstract ID: 34

C42 - Currarino Syndrome: A Rare Condition with Potential Connection to Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Alex Liu; Mohamad Sonbol; Thorvardur Halfdanarson

Abstract ID: 55

C43 - Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Kimberly Perez; Matthew Kulke; Lauren Brais; Rujuta Gadgil; Holly Alexander; Jonathan Nowak; John Garcia; Shan Yang; Ed Esplin; Sapna Syngal; Judy Garber; Jennifer Chan

Abstract ID: 58

C44 - Prognostic Impact of a Large Mesenteric Mass > 2 Cm in Ileal Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Yosuke Kasai; Kelly Mahuron; Kenzo Hirose; Carlos Corvera; Grace Kim; Thomas Hope; Brandon Shih; Robert Warren; Emily Bergsland; Eric Nakakura

Abstract ID: 64

C45 - Accuracy of Ki-67 Index Obtained from FNA Specimens in the Diagnosis and Grading of Pancreatic Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Austin Livingston; Erin Strong; Kathleen Christians; Susan Tsai; Abdul Khan; Kulwinder Dua; Bryan Hunt; Catherine Hagen; Douglas Evans; Callisia Clarke

Abstract ID: 68

C46 - Application of Chromogranin A and Chromogranin B in Advanced Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Yuanliang Li; Huangying Tan

Abstract ID: 72

C47 - High Ki67 Index is Indicative for Lymph Node Metastasis in Small Non-Functioning Pancreatic Neuroendocrine Neoplasms

Published in 2019 Listed under Clinical

Toshihiko Masui; Kazuyuki Nagai; Takayuki Anazawa; Kenzo Nakano; Yuichiro Uchida; Akitada Yogo; Norio Emoto; Kyoichi Takaori; Shinji Uemoto

Abstract ID: 74

C48 - Factors Associated with Dying from Pancreatic Neuroendocrine Tumor

Published in 2019 Listed under Clinical

Erin Strong; Austin Livingston; Susan Tsai; Kathleen Christians; Ben George; Paul Ritch; James Thomas; Kulwinder Dua; Abdul Khan; Brian Hunt; William Hunt; Beth Erickson; Douglas Evans; Callisia Clarke

Abstract ID: 75

C5 - Effect of Telotristat Ethyl on Cardiac Valve Degeneration

Published in 2019 Listed under Clinical

Xinmei Wang; Danielle Kuban-Johnston; Pablo Lapuerta; Carla Lacerda

Abstract ID: 80

C50 - Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors

Published in 2019 Listed under Clinical

Malcolm Squires; Patrick Worth; Bhavana Konda; Manisha Shah; Mary Dillhoff; Sherif Abdel-Misih; Timothy Pawlik; Carl Schmidt; George Poultsides; Jordan Cloyd

Abstract ID: 86

C51 - NETs Arising in a Meckel’s Diverticulum: Do They Behave Differently than Ileal NETs?

Published in 2019 Listed under Clinical

James De Andrade; Andrew Blakely; Andrew Nguyen; Gagandeep Singh; Byrne Lee; Phillip Ituarte

Abstract ID: 109

C52 - Does Lymphadenectomy Extent Impact Survival in Small Bowel Neuroendocrine Tumors?

Published in 2019 Listed under Clinical

James De Andrade; Andrew Blakely; Andrew Nguyen; Phillip Ituarte; Daneng Li,; Byrne Lee; Gagandeep Singh

Abstract ID: 110

C53 - Clinicopathological, Molecular and Genetic Characteristics of Thymic Tumors in Multiple Endocrine Neoplasia 1 Syndrome

Published in 2019 Listed under Clinical

Adel Mandl; James Welch; Jaydira Del Rivero; Craig Cochran; Roxanne Merkel; David Schrump; William Simonds; Robert Jensen; Lee Weinstein; Sunita Agarwal; Jenny Blau, R. Ripleyz; Vaishali Parekh; Gayathri Veeraraghavan; Zahraa Sater

Abstract ID: 129

C54 - Prediction of Survival for Pancreatic Neuroendocrine Tumors: A Systematic Review of Clinical Tools

Published in 2019 Listed under Clinical

George Ho; Kaitlyn Beyfuss; Sten Myrehaug; David Chan; Victoria Zuk; Calvin Law; Alyson Mahar; Julie Hallet

Abstract ID: 131

C55 - Patterns of Care and Outcomes in Localized, Grad 3, Gastroenteropancreatice Neuroendocrine Neoplasms: A 10-Year Experience in a Tertiary Centre

Published in 2019 Listed under Clinical

Ivan Lyra Gonzalez; Stephanie Moignard; Charles Lim; Osvaldo Espin Garcia; Ozgur Mete; Carol-Anne Moulton; Monika Krzyzanowska; Raymond Jang

Abstract ID: 137

C56 - Association between Preoperative Vasostatin-1 and Pathological Features of Aggressiveness in Localized Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNET)

Published in 2019 Listed under Clinical

Valentina Andreasi; Stefano Partelli; Marco Manzoni; Francesca Muffatti; Barbara Colombo; Angelo Corti; Massimo Falconi

Abstract ID: 151

C57 - Metastatic Potential of Small Pancreatic Neuroendocrine Tumors: Not as Innocent as They Seem

Published in 2019 Listed under Clinical

Eduardo Vega; Onur Kutlu; Omid Salehi; Daria James; Olga Kozyreva; Jennifer Chan; Claudius Conrad

Abstract ID: 155

C58 - Management of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors: Limitations to Apply Guidelines into Real Life

Published in 2019 Listed under Clinical

Valentina Andreasi; Stefano Partelli; Michele Mazza; Francesca Muffatti; Stefano Crippa; Domenico Tamburrino; Massimo Falconi

Abstract ID: 159

C59 - Presacral Neuroendocrine Tumors Associated with the Currarino Syndrome

Published in 2019 Listed under Clinical

Aaron Scott; Jonathon Tessmann; Terry Braun; Bart Brown; Patrick Breheny; Benjamin Darbro; Andrew Bellizzi; Joseph Dillon; Thomas O'Dorisio; Alice Alderson; Bonita Bennett; John Bernat; David Metz; James Howe

Abstract ID: 167

C6 - Randomized Phase II Trial of Pazopanib versus Placebo in Patients (Pts) with Progressive Carcinoid Tumors (CARC) (Alliance A021202)

Published in 2019 Listed under Clinical

Emily Bergsland; Michelle Mahoney; Tim Asmis; Nathan Hall; Priya Kumthekar; Michael Maitland; Donna Neidzwiecki; Andrew Nixon; Eileen O’Reilly; Lawrence Schwartz; Jeff Sloan; Jonathan Strosberg; Jeff Meyerhardt

Abstract ID: 85

C7 - Outcomes after Cessation of Therapy with Alkylating Agents (AA) For Pancreatic Neuroendocrine Tumors (PanNETs)

Published in 2019 Listed under Clinical

Y. Linda Wu; Diane Reidy; Agata Bielska; Virginia Kelly; Nitya Raj

Abstract ID: 92

C8 - Analysis of Factors Related to Gallstones in Patients with Neuroendocrine Tumors Treated with Long-Acting Somatostatin Analogues

Published in 2019 Listed under Clinical

Zhirong Qi; Xudong Qiu; Yuanliang Li; Dou Dou; Jie Luo; Fei Su; Huangying Tan

Abstract ID: 97

C9 - PD-1 Blockade in Advanced Adrenocortical Carcinoma

Published in 2019 Listed under Clinical

Nitya Raj; Youyun Zheng; Virginia Kelly; Seth Katz; Joanne Chou; Richard Do; Marinela Capanu; Dmitriy Zamarin; Leonard Saltz; Charlotte Ariyan; Brian Untch; Eileen O’Reilly; Anuradha Gopalan; Michael Berger; Elly Olino; Neil Segal; Diane Reidy

Abstract ID: 118

P1 - Geographic and Demographic Disparities in Neuroendocrine Tumors (NETs): A Population-Based Study

Published in 2019 Listed under Population Science

Rohit Gosain; Somedeb Ball; Navpreet Rana; Adrienne Groman; Elizabeth Gage-Bouchard; Arvind Dasari; Sarbajit Mukherjee

Abstract ID: 22

P10 - Gastro-Entero-Pancreatic Neuroendocrine Tumors in Young Adults - Fare Better Than Older Patients

Published in 2019 Listed under Population Science

Andrew Nguyen; Camille Stewart; Christopher Larocca; James De Andrade; Phillip Ituarte; Byrne Lee; Sue Chang; Jonathan Kessler; Daneng Li; Gagandeep Singh

Abstract ID: 91

P12 - Real-World Comparative Analysis of Lanreotide and Octreotide Long-Acting Release (Lar) Use for Neuroendocrine Tumors (NETs) in Canada

Published in 2019 Listed under Population Science

Jonathan Loree; Marion Feuilly; Callahan Laforty; Anna Liovas; Heather McKechnie; Winson Cheung

Abstract ID: 96

P13 - Understanding the Treatment Preferences of Neuroendocrine Tumour Patients Using Discrete Choice Experiments

Published in 2019 Listed under Population Science

Matthew Anaka; David Chan; Sharon Pattison; Alia Thawer; Bryan Franco; Lesley Moody; Christopher Jackson; Eva Segelov; Simron Singh

Abstract ID: 112

P14 - Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN)

Published in 2019 Listed under Population Science

Teodora Kolarova; Simone Leyden; Catherine Bouvier; Dirk Van Genechten; Ronald Hollander

Abstract ID: 122

P16 - Renal Neuroendocrine Tumors: Definitive Surgery is the Cornerstone of Longevity

Published in 2019 Listed under Population Science

Andrew Nguyen; James De Andrade; Christopher Larocca; Camille Stewart; Phillip Ituarte; Jonathan Kessler; Gagandeep Singh; Sue Chang; Daneng Li

Abstract ID: 138

P17 - DIPNECH: The Mayo Experience

Published in 2019 Listed under Population Science

Daniel Almquist; Arriana Cabrera; Heidi Kosiorek; Mohamad Sonbol; Thorvardur Halfdanarson; Helen Ross; Dawn Jaroszewski; Harshita Paripati

Abstract ID: 141

P18 - Incidence and Survival Patterns of Gastroenteropancreatic Neuroendocrine Neoplasms in California

Published in 2019 Listed under Population Science

Alan Paciorek; Brandon Shih; Meg McKinley; Iona Cheng; Li Zhang; Claire Mulvey; Ann Griffin; Eric Nakakura; Katherine Van Loon; Emily Bergsland

Abstract ID: 161

P19 - Symptom Burden at the End of Life for Neuroendocrine Tumors: A Population-Based Analysis of Patient-Reported Outcomes

Published in 2019 Listed under Population Science

Julie Hallet; Laura Davis; Alyson Mahar; Calvin Law; Elie Isenberg-Grzeda; Sten Myrehaug; Haoyu Zhao; Kaitlyn Beyfuss; Lesley Moody; Natalie Coburn

Abstract ID: 166

P2 - Incidence and Survival Patterns of Pancreatic Neuroendocrine Tumors over the Last Two Decades: A SEER Database Analysis

Published in 2019 Listed under Population Science

Mohamad Sonbol; Gina Mazza; Jason Starr; Timothy Hobday; Thorvardur Halfdanarson

Abstract ID: 27

P20 - Differential Diagnosis (DDX) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR)

Published in 2019 Listed under Population Science

Mohid Khan; Thomas Walter; Amy Buchanan-Hughes; Lucie Keeber; Marion Feuilly; Enrique Grande

Abstract ID: 114

P3 - Satisfaction Survey of Administration Modes for Long-Acting (LA) Somatostatin Analog (SSA) Therapy in Patients with Neuroendocrine Tumors (NETs)

Published in 2019 Listed under Population Science

Christina Darden; David Ray; Grace Goldstein; Diana Goss; Diana Garbinsky; Lee Bennett; Mark Price; Ramya Thota

Abstract ID: 28

P4 - Care Excellence: A Survey of American NET Centers for Self-Assessment by Established Criteria

Published in 2019 Listed under Population Science

Cindy Lovelace; Margaret Bean; Eric Liu; George Fisher; Thomas O'Dorisio

Abstract ID: 45

P5 - Prevalence of Bone Metastases in Neuroendocrine Neoplasms by 68Ga DOTATATE PET Scan

Published in 2019 Listed under Population Science

Shagufta Shaheen; Rebecca Gardner; Vandana Sundaram; Kathleen Hornbacker; Farshad Moradi; Joy Wu; Pamela Kunz

Abstract ID: 51

P6 - Effect of Metastatic Site on Survival in Patients with Neuroendocrine Neoplasms (NENs): An Analysis of SEER Data from 2010 -2014

Published in 2019 Listed under Population Science

Nikolaos Trikalinos; Benjamin Tan; Manik Amin; Jingxia Lu; Ramaswamy Govindan; Daniel Morgensztern

Abstract ID: 67

P7 - Incidence Patterns of Adrenocortical Carcinomas and Malignant Pheochromocytomas and Paragangliomas in California

Published in 2019 Listed under Population Science

Claire Mulvey; Alan Paciorek; Brandon Shih; Meg McKinley; Dawn Pearson; Iona Cheng; Ann Griffin; Quan-Yang Duh; Sanziana Roman; Julie Sosa; Insoo Suh; Chienying Liu; Katherine Van Loon; Emily Bergsland

Abstract ID: 70

P8 - Trends and In-Hospital Outcomes of Neuroendocrine Tumors (NETs): A National Perspective

Published in 2019 Listed under Population Science

Aakash Desai; Thorvardur Halfdanarson

Abstract ID: 73

P9 - Computing the Cost of Care per Day for Patients with Metastatic NETs

Published in 2019 Listed under Population Science

Divya Gupta; Kristopher Kapphahn; FeiFei Qin; Kathleen Hornbacker; Solomon Henry; Douglas Wood; Douglas Blayney; Pamela Kunz

Abstract ID: 90

T1 - Randomized Embolization Trial for Neuroendocrine Tumors (RETNET): First Safety Report

Published in 2019 Listed under Trials In Progress

Michael Soulen; Rony Avritscher; Ghassan El-Haddad; Nicholas Fidelman; Ricardo Garcia-Monaco; Sarah White; E. Paul Wileyto

Abstract ID: 15

T2 - Analyses of Patient Diaries in the NETTER-1 Study of 177Lu-DOTATATE vs. High Dose OCTREOTIDE in Progressive Midgut Neuroendocrine Tumors

Published in 2019 Listed under Trials In Progress

Jonathan Strosberg; Edward Wolin; Beth Chasen; Matthew Kulke; David Bushnell; Caplin Martin; Richard Baum; Timothy Hobday; Andrew Hendifar; Paola Santoro; Per Broberg; Arnaud Demange; Kjell Öberg; Philippe Ruszniewski; Eric Krenning

Abstract ID: 99

T3 - Impact of Baseline Liver Tumor Burden, Alkaline Phosphatase (ALP) Elevation,and Target Size Lesion on Therapeutic Effect of 177Lu-DOTATATE Treatment: Analysis of Progression Free Survival, and Safety in NETTER-1 Study

Published in 2019 Listed under Trials In Progress

Jonathan Strosberg; Pamela Kunz; Andrew Hendifar; James Yao; David Bushnell; Matthew Kulke; Richard Baum; Caplin Martin; Philippe Ruszniewski; Ebrahim Delpassand; Timothy Hobday; Chris Verslype; Al Benson; Berna Polack; Beilei He; Paola Santoro; Eric Krenning

Abstract ID: 115